# Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment

> **NCT07651878** · PHASE1 · RECRUITING · sponsor: **Mendus** · enrollment: 24 (estimated)

## Conditions studied

- CML (Chronic Myelogenous Leukemia)

## Interventions

- **BIOLOGICAL:** vididencel

## Key facts

- **NCT ID:** NCT07651878
- **Lead sponsor:** Mendus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-14
- **Primary completion:** 2029-09-01
- **Final completion:** 2030-03-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-06-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07651878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07651878, "Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07651878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*